"Enalaprilat" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.
| Descriptor ID |
D015773
|
| MeSH Number(s) |
D12.644.456.345.360.300
|
| Concept/Terms |
Enalaprilat Dihydrate- Enalaprilat Dihydrate
- Dihydrate, Enalaprilat
- 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
- Enalaprilic Acid
|
Below are MeSH descriptors whose meaning is more general than "Enalaprilat".
Below are MeSH descriptors whose meaning is more specific than "Enalaprilat".
This graph shows the total number of publications written about "Enalaprilat" by people in this website by year, and whether "Enalaprilat" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Enalaprilat" by people in Profiles.
-
Perioperative hypertension management. Vasc Health Risk Manag. 2008; 4(3):615-27.
-
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. J Am Coll Cardiol. 2007 Apr 17; 49(15):1607-1610.
-
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation. 2002 Jun 11; 105(23):2785-90.
-
Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension. J Cardiovasc Pharmacol. 1985 Jul-Aug; 7(4):767-76.